Follow
Auliya Suwantika
Auliya Suwantika
Researcher of Pharmacoeconomics, Padjadjaran University
Verified email at unpad.ac.id
Title
Cited by
Cited by
Year
The potential impact of COVID-19 pandemic on the immunization performance in Indonesia
AA Suwantika, C Boersma, MJ Postma
Expert Review of Vaccines 19 (8), 687-690, 2020
442020
Cost-utility analysis of human papillomavirus vaccination and cervical screening on cervical cancer patient in Indonesia
D Setiawan, FC Dolk, AA Suwantika, TA Westra, JC WIlschut, MJ Postma
Value in Health Regional Issues 9, 84-92, 2016
292016
Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account
AA Suwantika, HAT Tu, MJ Postma
Vaccine 31 (32), 3300-3307, 2013
262013
An economic evaluation of diabetes mellitus management in South East Asia
A Priyadi, A Muhtadi, AA Suwantika, SA Sumiwi
Journal of Advanced Pharmacy Education & Research| Apr-Jun 9 (2), 53-74, 2019
242019
Artikel Ulasan: Tinjauan Bahan Berbahaya dalam Krim Pencerah Kulit
R Haryanti, A Suwantika, M Abdassah
Farmaka 16 (2), 214-224, 2013
222013
The cost–effectiveness of HPV vaccination in addition to screening: a Dutch perspective
D Setiawan, J Luttjeboer, TA Westra, JC Wilschut, AA Suwantika, ...
Expert review of vaccines 14 (4), 589-604, 2015
212015
Economic evaluations of dengue vaccination in the southeast Asia region: evidence from a systematic review
W Supadmi, AA Suwantika, DA Perwitasari, R Abdulah
Value in health regional issues 18, 132-144, 2019
202019
Economic evaluations of hepatitis A vaccination in middle-income countries
AA Suwantika, S Yegenoglu, A Riewpaiboon, HAT Tu, MJ Postma
Expert review of vaccines 12 (12), 1479-1494, 2013
202013
Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward
J Lou, KC Sarin, KY Toh, S Dabak, A Adler, J Ahn, DBS Bayani, K Chan, ...
International journal of technology assessment in health care 36 (5), 474-480, 2020
172020
Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia
AA Suwantika, MJ Postma
BMC Public Health 13 (1), 1-9, 2013
172013
incidence, causative drugs, and economic consequences of drug-induced sJs, Ten, and sJs–Ten overlap and potential drug–drug interactions during treatment: a retrospective …
R Abdulah, TF Suwandiman, N Handayani, DP Destiani, AA Suwantika, ...
Therapeutics and clinical risk management 13, 919, 2017
152017
Cost-effectiveness of hepatitis A vaccination in Indonesia
AA Suwantika, P Beutels, MJ Postma
Human vaccines & immunotherapeutics 10 (8), 2342-2349, 2014
152014
Accelerating the introduction of rotavirus immunization in Indonesia
AA Suwantika, N Zakiyah, K Lestari, MJ Postma
Expert review of vaccines 13 (4), 463-472, 2014
132014
Farmakoekonomi modeling
D Setiawan, D Endarti, A Suwantika
Purwokerto: UM Purwokerto Press, 2017
102017
Impact of switch options on the economics of pneumococcal conjugate vaccine (PCV) introduction in Indonesia
AA Suwantika, N Zakiyah, ASW Kusuma, R Abdulah, MJ Postma
Vaccines 8 (2), 233, 2020
92020
Risk factors of lung cancer in Indonesia: A qualitative study
MG Sholih, DA Perwitasari, R Hendriani, H Sukandar, MI Barliana, ...
J. Adv. Pharm. Educ. Res| Apr-Jun 9 (2), 41-45, 2019
92019
Cost-Effectiveness of Dengue Vaccination in Indonesia: Considering Integrated Programs with Wolbachia-Infected Mosquitos and Health Education
AA Suwantika, AP Kautsar, W Supadmi, N Zakiyah, R Abdulah, M Ali, ...
International Journal of Environmental Research and Public Health 17 (12), 4217, 2020
82020
Satisfaction level of patients, physicians, and private primary healthcare center managers with chronic disease management program in Indonesia
RK Sinuraya, R Abdulah, A Diantini, AA Suwantika
Value in Health 19 (7), A869, 2016
82016
COVID-19 pandemic disruption on the management of tuberculosis treatment in Indonesia
GJ Caren, D Iskandar, DAE Pitaloka, R Abdulah, AA Suwantika
Journal of multidisciplinary healthcare 15, 175, 2022
72022
How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making
S Botwright, AL Kahn, R Hutubessy, P Lydon, J Biey, AK Sidibe, I Diarra, ...
Vaccine: X 6, 100078, 2020
72020
The system can't perform the operation now. Try again later.
Articles 1–20